Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
3.190
+0.070 (2.24%)
Feb 21, 2025, 4:00 PM EST - Market closed
Alto Neuroscience Market Cap
Alto Neuroscience has a market cap or net worth of $86.03 million as of February 21, 2025. Its market cap has decreased by -84.55% in one year.
Market Cap
86.03M
Enterprise Value
-80.18M
1-Year Change
-84.55%
Ranking
Category
Stock Price
$3.19
Market Cap Chart
Since the IPO on February 2, 2024, Alto Neuroscience's market cap has decreased from $409.04M to $86.03M, a decrease of -78.97%. That is a compound annual growth rate of -77.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2025 | 84.15M | -26.24% |
| Dec 31, 2024 | 114.08M | -72.11% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |